Jeehae Park, Ph.D.
Principal Scientist, High Throughput Analytics
Meet the rest of our
see all team members
Nia Tatsis, Ph.D.
Executive Vice President and Chief Regulatory and Quality Officer, Vertex Pharmaceuticals
Michael MacLean
Chief Financial Officer and Chief Business Officer, Avidity Biosciences
Sekar Kathiresan, M.D.
Co-Founder, Chief Executive Officer and Board Member
Bo Cumbo
President and Chief Executive Officer, Solid Biosciences
Andrew Geall, Ph.D.
Co-Founder and Chief Development Officer, Replicate Bioscience
Krishna Yeshwant, M.D.
Managing Partner, GV
Daniel J. Rader, M.D.
Chair, Department of Genetics, University of Pennsylvania
Allison Dorval
Chief Financial Officer
Barry Ticho, M.D., Ph.D.
Chief Medical Officer, Stoke Therapeutics
Leslie Stolz, Ph.D.
Senior Vice President, Regulatory Affairs
Andrew Ashe, J.D.
President, Chief Operating Officer and General Counsel
J. Keith Joung, M.D., Ph.D.
Robert B. Colvin, M.D. Endowed Chair in Pathology and Pathologist, Massachusetts General Hospital; Professor of Pathology, Harvard Medical School
Yasser (Yas) El-Gamal, J.D.
Senior Vice President, Legal Affairs and Chief Intellectual Property Counsel
Troy Lister, Ph.D.
Chief Scientific Officer
Kiran Musunuru, M.D., Ph.D.
Professor of Cardiovascular Medicine and Genetics, Perelman School of Medicine at the University of Pennsylvania
Anthony Philippakis, M.D., Ph.D.
Chief Data Officer, Broad Institute of MIT and Harvard
Fred Fiedorek, M.D.
Chief Medical Officer
Lonnel Coats
Chief Executive Officer and Director, Lexicon Pharmaceuticals
Joan Nickerson
Chief Administrative Officer
Jodie Morrison
Chief Executive Office and Director, Q32 Bio Inc.
Eugene Braunwald, M.D.
Distinguished Hersey Professor of Medicine at Harvard Medical School
Jason Politi
Chief Technical Operations Officer
Issi Rozen
Venture Partner, GV
Burt Adelman, M.D.
Chairman of the Board; former EVP and Chief Medical Officer, Dyax
